Barr Looks To Build Upon Duramed Branded Unit
This article was originally published in The Pink Sheet Daily
Executive Summary
Company wants to leverage expertise in oral contraceptive and hormone therapy to other female therapeutics.
You may also be interested in...
Role Reversal: Barr May Seek A Settlement To Thwart Generic Seasonale
Barr's request for patent re-issue was rejected by PTO, opening the door for Watson to launch generic Seasonale in September.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.